Immunogenicity of Hepatitis B Vaccines

JAMA: The Journal of the American Medical Association

Volumn 272, Issue 3, 1994, Pages 201-

  Koff, Raymond S ^a  

^a METROWEST MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENGERIX-B; HEPATITIS B ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE; RECOMBINANT VACCINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

BIOSYNTHESIS; HUMAN; IMMUNOLOGY; NOTE; SKIN TEST; ADULT; AGED; ANTIBODY TITER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; HEALTH CARE PERSONNEL; HEPATITIS B; IMMUNOGENICITY; LETTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

HEPATITIS B ANTIGENS; HEPATITIS B VACCINES; HUMAN; VACCINES, SYNTHETIC; SKIN TESTS;

EID: 1642500322     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1994.03520030041018     Document Type: Letter

References (4)

1. Margolis HS, Presson AC. Host factors related to poor immunogenicity of hepatitis B vaccine in adults: another reason to immunize early. JAMA. 1993;270:2971-2972.
2. Roome AJ, Walsh SJ, Cartter ML, Hadler JL. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA. 1993;270:2931-2934.
3. Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M. Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA. 1993;270:2935-2939.
4. Treadwell TL, Keeffe EB, Lake J, et al. Immunogenicity of two recombinant hepatitis B vaccines in older individuals. Am J Med. 1993;95:584-588.